CytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial

Go back to CytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial
Cytosorbents Corporation (NASDAQ: CTSO) Delayed: 0.31 -0.05 (13.89%)
Previous Close $0.36    52 Week High $7.48 
Open $0.36    52 Week Low $3.11 
Day High $0.39    P/E N/A 
Day Low $0.30    EPS $-0.03 
Volume 223,833